NCT00723970View on ClinicalTrials.gov

Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Major Depressive DisorderInsomniaHot Flashes
Interventions
DRUG

Quetiapine Extended Release

Quetiapine XR, 150-300 mg QHS, for 8 weeks

Trial Locations (1)

L8P 3B6

Women's Health Concerns Clinic (WHCC), Hamilton

All Listed Sponsors
lead

McMaster University

OTHER

NCT00723970 - Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression | Biotech Hunter | Biotech Hunter